Boothbay Fund Management, LLC Corcept Therapeutics Inc Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$29.51 - $46.26 $1.84 Million - $2.88 Million
-62,200 Reduced 69.73%
27,000 $1.25 Million
Q2 2024

Aug 14, 2024
BUY
$22.21 - $34.48 $193,227 - $299,976
8,700 Added 10.81%
89,200 $2.9 Million
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $173,020 - $225,172
8,200 Added 11.34%
80,500 $2.03 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $1.79 Million - $2.38 Million
72,300 New
72,300 $2.35 Million

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email